Octadecyl 3-(3, 5-di-tert-butyl-4-hydroxyphenyl) propanoate nanosponges: enhanced antibacterial and antibiofilm activity against multidrug-resistant <i>Klebsiella pneumoniae</i> with synergistic ceftriaxone combination.

Front Cell Infect Microbiol · 2026 · PMC13422199 · PMID 42534733

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

Statistical analysis using the Wilcoxon test confirmed that the differences between ODHP and ODHP-NS at 1/2 MIC and 1/4 MIC were highly significant ( p < 0.0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Octadecyl 3-(3, 5-di-tert-butyl-4-hydroxyphenyl) propanoate nanosponges: enhanced antibacterial and antibiofilm activity against multidrug-resistant &lt;i&gt;Klebsiella pneumoniae&lt;/i&gt; with synergistic ceftriaxone combination.

The sentences

Octadecyl 3-(3, 5-di-tert-butyl-4-hydroxyphenyl) propanoate nanosponges: enhanced antibacterial and antibiofilm activity against multidrug-resistant <i>Klebsiella pneumoniae</i> with synergistic ceftriaxone combination.